Increased expression of cystine/glutamate antiporter in multiple sclerosis

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Pampliega, Olatz ^a,d   Domercq, María ^a   Soria, Federico N ^a   Villoslada, Pablo ^b   Rodríguez Antigüedad, Alfredo ^c   Matute, Carlos ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c HOSPITAL DE BASURTO   (Spain)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPORTER; CYSTINE GLUTAMATE ANTIPORTER; GLUTAMIC ACID; UNCLASSIFIED DRUG; AMINO ACID TRANSPORTER; CYSTINE; GLUTATHIONE; SLC7A11 PROTEIN, HUMAN; XCT PROTEIN, RAT;

ADULT; ALLERGIC ENCEPHALOMYELITIS; AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CELL; CELL CULTURE; CELL STRAIN U937; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATING DISEASE; ENZYME ACTIVE SITE; EXCITOTOXICITY; FEMALE; FLOW CYTOMETRY; GLUTAMATE HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MICROGLIA; MONOCYTE; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RAT; UPREGULATION; WESTERN BLOTTING; AGED; ANIMAL; CELL LINE; GENETICS; HOMEOSTASIS; LEWIS RAT; METABOLISM; MIDDLE AGED; OPTIC NERVE; PATHOLOGY; PATHOPHYSIOLOGY; SPINAL CORD;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID TRANSPORT SYSTEM Y+; ANIMALS; CELL LINE; CYSTINE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GLUTAMIC ACID; GLUTATHIONE; HOMEOSTASIS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OPTIC NERVE; RATS; RATS, INBRED LEW; SPINAL CORD; YOUNG ADULT;

EID: 79957823478     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-63     Document Type: Article

References (43)

1. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998, 338:278-285. 10.1056/NEJM199801293380502, 9445407.
2. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 1999, 122:2279-2295. 10.1093/brain/122.12.2279, 10581222.
3. Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 2004, 55:458-468. 10.1002/ana.20016, 15048884.
4. Hemmer B, Archelos JJ, Hartung HP. New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 2002, 3:291-301.
5. Matute C, Sanchez-Gomez MV, Martinez-Millan L, Miledi R. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc Natl Acad Sci USA 1997, 94:8830-8835. 10.1073/pnas.94.16.8830, 23152, 9238063.
6. McDonald JW, Althomsons SP, Hyrc KL, Choi DW, Goldberg MP. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptormediated excitotoxicity. Nat Med 1998, 4:291-297. 10.1038/nm0398-291, 9500601.
7. Pitt D, Werner P, Raine CS. Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 2000, 6:67-70. 10.1038/71555, 10613826.
8. Smith T, Groom A, Zhu B, Turski L. Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med 2000, 6:62-66. 10.1038/71548, 10613825.
9. Groom AJ, Smith T, Turski L. Multiple sclerosis and glutamate. Ann N Y Acad Sci 2003, 993:229-275. 10.1111/j.1749-6632.2003.tb07533.x, 12853317.
10. Matute C. Characteristics of acute and chronic kainate excitotoxic damage to the optic nerve. Proc Natl Acad Sci USA 1998, 95:10229-10234. 10.1073/pnas.95.17.10229, 21490, 9707629.
11. Stover JF, Pleines UE, Morganti-Kossmann MC, Kossmann T, Lowitzsch K, Kempski OS. Neurotransmitters in cerebrospinal fluid reflect pathological activity. Eur J Clin Invest 1997, 27:1038-1043. 10.1046/j.1365-2362.1997.2250774.x, 9466133.
12. Srinivasan R, Sailasuta N, Hurd R, Nelson S, Pelletier D. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain 2005, 128:1016-1025. 10.1093/brain/awh467, 15758036.
13. Pampliega O, Domercq M, Villoslada P, Sepulcre J, Rodriguez-Antiguedad A, Matute C. Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis. J Neuroimmunol 2008, 195:194-198. 10.1016/j.jneuroim.2008.01.011, 18378006.
14. Matute C, Alberdi E, Domercq M, Perez-Cerda F, Perez-Samartin A, Sanchez-Gomez MV. The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci 2001, 24:224-230. 10.1016/S0166-2236(00)01746-X, 11250007.
15. Matute C, Domercq M, Sanchez-Gomez MV. Glutamate-mediated glial injury: mechanisms and clinical importance. Glia 2006, 53:212-224. 10.1002/glia.20275, 16206168.
16. Nedergaard M, Takano T, Hansen AJ. Beyond the role of glutamate as a neurotransmitter. Nat Rev Neurosci 2002, 3:748-755.
17. King IL, Dickendesher TL, Segal BM. Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 2009, 113:3190-3197. 10.1182/blood-2008-07-168575, 2665891, 19196868.
18. Kouwenhoven M, Teleshova N, Ízenci V, Press R, Link H. Monocytes in multiple sclerosis: phenotype and cytokine profile. J Neuroimmunol 2001, 112:197-205. 10.1016/S0165-5728(00)00396-9, 11108949.
19. Baker DA, Shen H, Kalivas PW. Cystine/glutamate exchange serves as the source for extracellular glutamate: modifications by repeated cocaine administration. Amino Acids 2002, 23(1-3):161-162. 10.1007/s00726-001-0122-6, 12373531.
20. Lo M, Wang YZ, Gout PW. The x(c)- cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases. J Cell Physiol 2008, 251(3):593-602.
21. Vallejo-Illarramendi A, Domercq M, Perez-Cerda F, Ravid R, Matute C. Increased expression and function of glutamate transporters in multiple sclerosis. Neurobiol Dis 2006, 21:154-164. 10.1016/j.nbd.2005.06.017, 16061389.
22. Domercq M, Sanchez-Gomez MV, Sherwin C, Etxebarria E, Fern R, Matute C. System xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes. J Immunol 2007, 178:549-6556.
23. Vandesompele J, De PK, Pattyn F, Poppe B, Van RN, De PA, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3:RESEARCH0034.1-0034.12.
24. Matute C, Torre I, Pérez-Cerdá F, Pérez-Samartín A, Alberdi E, Etxebarria E, Arranz AM, Ravid R, Rodríguez-Antigüedad A, Sánchez-Gómez M, Domercq M. P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J Neurosci 2007, 27(35):525-9533.
25. Piani D, Fontana A. Involvement of the cystine transport system xc- in the macrophage-induced glutamate-dependent cytotoxicity to neurons. J Immunol 1994, 152:3578-3585.
26. Qin S, Colin C, Hinners I, Gervais A, Cheret C, Mallat M. System xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40. J Neurosci 2006, 26:3345-3356. 10.1523/JNEUROSCI.5186-05.2006, 16554485.
27. McBean GJ. Cerebral cystine uptake: a tale of two transporters. Trends Pharmacol Sci 2002, 23:299-302. 10.1016/S0165-6147(02)02060-6, 12119142.
28. Sarchielli P, Greco L, Floridi A, Floridi A, Gallai V. Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid. Arch Neurol 2003, 60:1082-1088. 10.1001/archneur.60.8.1082, 12925363.
29. Keegan BM, Noseworthy JH. Multiple sclerosis. Annu Rev Med 2002, 53:285-302. 10.1146/annurev.med.53.082901.103909, 11818475.
30. Yawata I, Takeuchi H, Doi Y, Liang J, Mizuno T, Suzumura A. Macrophage induced neurotoxicity is mediated by glutamate and attenuated by glutaminase inhibitors and gap junction inhibitors. Life Sci 2008, 82:1111-1116. 10.1016/j.lfs.2008.03.010, 18452953.
31. Sato H, Fujiwara K, Sagara J, Bannai S. Induction of cystine transport activity in mouse peritoneal macrophages by bacterial lipopolysaccharide. Biochem J 1995, 310:547-551. 1135929, 7654193.
32. Sato H, Kuriyama-Matsumura K, Hashimoto T, Sasaki H, Wang H, Ishii T, Mann GE, Bannai S. Effect of oxygen on induction of the cystine transporter by bacterial lipopolysaccharide in mouse peritoneal macrophages. J Biol Chem 2001, 276:10407-10412. 10.1074/jbc.M007216200, 11136724.
33. Baker DA, Xi ZX, Shen H, Swanson CJ, Kalivas PW. The origin and neuronal function of in vivo nonsynaptic glutamate. J Neurosci 2002, 22:9134-9141.
34. Takeuchi H, Jin S, Wang J, Zhang G, Kawanokuchi J, Kuno R, Sonobe Y, Mizuno T, Suzumura A. Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem 2006, 281:21362-21368. 10.1074/jbc.M600504200, 16720574.
35. Erdmann N, Zhao J, Lopez AL, Herek S, Curthoys N, Hexum TD, Tsukamoto T, Ferraris D, Zheng J. Glutamate production by HIV-1 infected human macrophage is blocked by the inhibition of glutaminase. J Neurochem 2007, 102:539-549. 10.1111/j.1471-4159.2007.04594.x, 1976281, 17596215.
36. Werner P, Pitt D, Raine CS. Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol 2001, 50:169-180. 10.1002/ana.1077, 11506399.
37. Shijie J, Takeuchi H, Yawata I, Sonobe Y, Doi Y, Liang J, Hua L, Yasuoka S, Zhou Y, Noda M, Kawanokuchi J, Mizuno T, Suzumura A. Blockade of glutamate release from microglia attenuates experimental autoimmune encephalomyelitis in mice. J Exp Med 2009, 217:87-92.
38. Shih AY, Erb H, Sun X, Toda S, Kalivas PW, Murphy TH. Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation. J Neurosci 2006, 26:10514-10523. 10.1523/JNEUROSCI.3178-06.2006, 17035536.
39. Lassmann H. Experimental autoimmune encephalomyelitis. Myelin biology and disorders 2004, 1039-1071. Elsevier Academic Press, Lazzarini RA.
40. Fogal B, Li J, Lobner D, McCullough LD, Hewett SJ. System x(c)- activity and astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injury. J Neurosci 2007, 27:10094-10105. 10.1523/JNEUROSCI.2459-07.2007, 17881516.
41. Savaskan NE, Heckel A, Hahnen E, Engelhorn T, Doerfler A, Ganslandt O, Nimsky C, Buchfelder M, Eyupoglu IY. Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema. Nat Med 2008, 14:629-632. 10.1038/nm1772, 18469825.
42. Massie A, Schallier A, Mertens B, Vermoesen K, Bannai S, Sato H, Smolders I, Michotte Y. Time-dependent changes in striatal xCT protein expression in hemi-Parkinson rats. Neuroreport 2008, 19:1589-1592. 10.1097/WNR.0b013e328312181c, 18806690.
43. Sato H, Shiiya A, Kimata M, Maebara K, Tamba M, Sakakura Y, Makino N, Sugiyama F, Yagami K, Moriguchi T, Takahashi S, Bannai S. Redox imbalance in cystine/glutamate transporter-deficient mice. J Biol Chem 2005, 280:37423-37429. 10.1074/jbc.M506439200, 16144837.